"White House Challenges Patents on Taxpayer-Funded High-Priced Drugs"
The Biden administration has announced a plan to potentially cancel the patent protection of high-priced drugs developed with taxpayer money, allowing competitors to produce their own versions in an effort to lower costs. The government would consider overriding patents for drugs that are only available to a limited group of consumers. Pharmaceutical companies, who have relied on government research for drug development, are expected to challenge the plan in court. The administration is also targeting private equity firms that acquire and sell hospitals and health systems for profit.
